313 related articles for article (PubMed ID: 34769108)
1. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
Kłos P; Dabravolski SA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Control in Inflammatory Gastrointestinal Diseases.
Sui GY; Wang F; Lee J; Roh YS
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499214
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
Goel GA; Kandiel A; Achkar JP; Lashner B
Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
[TBL] [Abstract][Full Text] [Related]
6. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
[TBL] [Abstract][Full Text] [Related]
8. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
9. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer.
Liang L; Lin R; Xie Y; Lin H; Shao F; Rui W; Chen H
Int J Biol Sci; 2021; 17(10):2548-2560. PubMed ID: 34326693
[TBL] [Abstract][Full Text] [Related]
10. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
Jackson DN; Theiss AL
Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
[TBL] [Abstract][Full Text] [Related]
11. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
Frigerio S; Lartey DA; D'Haens GR; Grootjans J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
[TBL] [Abstract][Full Text] [Related]
12. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
[TBL] [Abstract][Full Text] [Related]
14. Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.
Cassotta M; Cianciosi D; De Giuseppe R; Navarro-Hortal MD; Armas Diaz Y; Forbes-Hernández TY; Pifarre KT; Pascual Barrera AE; Grosso G; Xiao J; Battino M; Giampieri F
Nutrition; 2023 Jun; 110():111980. PubMed ID: 36965240
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer in patients with inflammatory bowel disease.
Vagefi PA; Longo WE
Clin Colorectal Cancer; 2005 Jan; 4(5):313-9. PubMed ID: 15663834
[TBL] [Abstract][Full Text] [Related]
16. Role of Inflammation in the Development of Colorectal Cancer.
Muthusami S; Ramachandran IK; Babu KN; Krishnamoorthy S; Guruswamy A; Queimado L; Chaudhuri G; Ramachandran I
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):77-90. PubMed ID: 32901590
[TBL] [Abstract][Full Text] [Related]
17. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
[TBL] [Abstract][Full Text] [Related]
18. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
Samadder NJ; Mukherjee B; Huang SC; Ahn J; Rennert HS; Greenson JK; Rennert G; Gruber SB
Cancer; 2011 Apr; 117(8):1640-8. PubMed ID: 21472711
[TBL] [Abstract][Full Text] [Related]
19. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
20. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
